INCY
insider transactionsINCYTE CORP — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-102.2K
0 buy · 102.2K sell
Net value · 365d
-$10.1M
$0 in · $10.1M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
8
0 buy · 102.2K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
Director
$0
766 sh
Own New
-
Grant·A
Director
$0
454 sh
Own +41%
-
Grant·A
Director
$0
17.3K sh
Own New
-
Grant·A
Director
$0
9.2K sh
Own New
-
Grant·A
Director
$0
6.1K sh
Own New
-
Grant·A
Director
$0
1.6K sh
Own +12%
-
Grant·A
Director
$0
6.1K sh
Own New
-
Grant·A
Director
$0
1.6K sh
Own +8%
-
Grant·A
Director
$0
6.1K sh
Own New
-
Grant·A
Director
$0
1.6K sh
Own +8%
-
Grant·A
Director
$0
6.1K sh
Own New
-
Grant·A
Director
$0
1.6K sh
Own +7%
-
Grant·A
Director
$0
6.1K sh
Own New
-
Grant·A
Director
$0
1.6K sh
Own +15%
-
Exercise·M
Principal Accounting Officer · 10b5-1
$0
2.6K sh
Own New
-
Sell·S
Principal Accounting Officer · 10b5-1
$263.9K
2.6K sh · $100.00
Own -11%
-
Exercise·M
Principal Accounting Officer · 10b5-1
$221.2K
2.6K sh · $83.83
Own +12%
-
Other·F
Pablo J Cagnoni KEY
President, Global Head of R&D
$2.4M
25.5K sh · $95.59
Own -10%
-
Sell·S
Principal Accounting Officer · 10b5-1
$199.7K
2.1K sh · $97.35
Own -9%
-
Exercise·M
Director · 10b5-1
$0
15.0K sh
Own New
-
Sell·S
Director · 10b5-1
$1.4M
15.0K sh · $94.93
Own -39%
-
Exercise·M
Director · 10b5-1
$1.3M
15.0K sh · $84.53
Own +63%
-
Grant·A
CMO & Head of Late-Stage Dev.
$0
44.1K sh
Own +129%
-
Grant·A
Pablo J Cagnoni KEY
President, Global Head of R&D
$0
31.5K sh
Own +13%
-
Grant·A
Suketu Upadhyay KEY
EVP & Chief Financial Officer
$0
13.2K sh
Own +100%
-
Grant·A
Suketu Upadhyay KEY
EVP & Chief Financial Officer
$0
38.4K sh
Own New
-
Grant·A
Suketu Upadhyay KEY
EVP & Chief Financial Officer
$0
26.3K sh
Own New
-
Exercise·M
Pablo J Cagnoni KEY
President, Global Head of R&D · 10b5-1
$0
12.6K sh
Own +83%
-
Exercise·M
Pablo J Cagnoni KEY
President, Global Head of R&D · 10b5-1
$0
6.1K sh
Own +29%
-
Sell·S
Pablo J Cagnoni KEY
President, Global Head of R&D · 10b5-1
$1.8M
18.7K sh · $96.50
Own -7%
-
Exercise·M
Pablo J Cagnoni KEY
President, Global Head of R&D · 10b5-1
$905.6K
12.6K sh · $71.93
Own +5%
-
Exercise·M
Pablo J Cagnoni KEY
President, Global Head of R&D · 10b5-1
$390.4K
6.1K sh · $64.25
Own +2%
-
Grant·A
CMO & Head of Late-Stage Dev.
$0
39.0K sh
Own +114%
-
Exercise·M
William Meury KEY
Chief Executive Officer
$0
125.0K sh
Own +346%
-
Grant·A
Pablo J Cagnoni KEY
President, Global Head of R&D
$0
27.9K sh
Own +12%
-
Grant·A
Director
$25.3K
269 sh · $94.12
Own +1%
-
Grant·A
Director
$24.9K
265 sh · $94.12
Own +1%
-
Other·F
EVP, GM, Dermatology US
$49.5K
537 sh · $92.23
Own -3%
-
Other·D
Director
—
5.4K sh
Own -100%
-
Other·D
Director
—
20.6K sh
Own -79%
-
Exercise·M
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$0
11.5K sh
Own +54%
-
Exercise·M
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$0
7.2K sh
Own +370%
-
Sell·S
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$1.8M
18.7K sh · $94.24
Own -7%
-
Exercise·M
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$738.9K
11.5K sh · $64.25
Own +5%
-
Exercise·M
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$438.4K
7.2K sh · $61.18
Own +3%
-
Exercise·M
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$0
5.6K sh
Own +52%
-
Exercise·M
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$0
13.1K sh
Own New
-
Sell·S
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$1.9M
18.7K sh · $100.91
Own -7%
-
Exercise·M
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$341.1K
5.6K sh · $61.18
Own +2%
-
Exercise·M
Pablo J Cagnoni KEY
President, R&D · 10b5-1
$808.6K
13.1K sh · $61.76
Own +6%
-
Other·F
EVP, Head of Tech. Operations
$19.0K
185 sh · $102.67
Own -1%
-
Other·F
EVP, Head of Incyte Intl
$11.4K
111 sh · $102.67
Own -0%
-
Other·F
EVP, Head of Tech. Operations
$44.0K
429 sh · $102.62
Own -1%
-
Grant·A
EVP & Chief Scientific Officer
$0
4.2K sh
Own New
-
Grant·A
EVP, Head of US Oncology
$0
14.2K sh
Own New
-
Grant·A
EVP, GM, Dermatology US
$0
8.5K sh
Own New
-
Grant·A
Principal Accounting Officer
$0
2.4K sh
Own New
-
Grant·A
EVP, Head of Tech. Operations
$0
7.4K sh
Own +27%
-
Grant·A
EVP & Chief Medical Officer
$0
19.9K sh
Own New
-
Grant·A
EVP, Head of Incyte Intl
$0
8.9K sh
Own +30%
-
Grant·A
Pablo J Cagnoni KEY
President, R&D
$0
28.5K sh
Own New
-
Grant·A
Director
$0
54.9K sh
Own New
-
Sell·S
EVP, Head of US Oncology · 10b5-1
$1.2M
10.9K sh · $109.07
Own -14%
-
Other·F
EVP, Head of US Oncology · 10b5-1
$881.4K
8.3K sh · $106.66
Own -10%
-
Sell·S
EVP & Chief Medical Officer · 10b5-1
$1.6M
15.6K sh · $101.70
Own -31%
-
Other·F
EVP, Head of Tech. Operations
$25.1K
254 sh · $98.77
Own -1%
-
Other·F
EVP & Chief Medical Officer
$1.3M
13.3K sh · $98.77
Own -21%
-
Grant·A
Director
$24.2K
245 sh · $98.77
Own +1%
-
Grant·A
Director
$23.8K
241 sh · $98.77
Own +1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Jacqualyn A Fouse | Grant A | 766 | $0 |
| Jun 17, 2026 | Jacqualyn A Fouse | Grant A | 454 | $0 |
| Jun 17, 2026 | Paul J Clancy | Grant A | 17.3K | $0 |
| Jun 10, 2026 | Otis W Brawley | Grant A | 9.2K | $0 |
| Jun 8, 2026 | Katherine A High | Grant A | 6.1K | $0 |
| Jun 8, 2026 | Katherine A High | Grant A | 1.6K | $0 |
| Jun 8, 2026 | Edmund Harrigan | Grant A | 6.1K | $0 |
| Jun 8, 2026 | Edmund Harrigan | Grant A | 1.6K | $0 |
| Jun 8, 2026 | Jacqualyn A Fouse | Grant A | 6.1K | $0 |
| Jun 8, 2026 | Jacqualyn A Fouse | Grant A | 1.6K | $0 |
| Jun 8, 2026 | Paul J Clancy | Grant A | 6.1K | $0 |
| Jun 8, 2026 | Paul J Clancy | Grant A | 1.6K | $0 |
| Jun 8, 2026 | Otis W Brawley | Grant A | 6.1K | $0 |
| Jun 8, 2026 | Otis W Brawley | Grant A | 1.6K | $0 |
| Jun 4, 2026 | Thomas Tray 10b5-1 | Exercise M | 2.6K | $0 |
| Jun 4, 2026 | Thomas Tray 10b5-1 | Sell S | 2.6K | $263.9K |
| Jun 4, 2026 | Thomas Tray 10b5-1 | Exercise M | 2.6K | $221.2K |
| Jun 1, 2026 | Pablo J Cagnoni KEY | Other F | 25.5K | $2.4M |
| May 26, 2026 | Thomas Tray 10b5-1 | Sell S | 2.1K | $199.7K |
| May 19, 2026 | Paul J Clancy 10b5-1 | Exercise M | 15.0K | $0 |
| May 19, 2026 | Paul J Clancy 10b5-1 | Sell S | 15.0K | $1.4M |
| May 19, 2026 | Paul J Clancy 10b5-1 | Exercise M | 15.0K | $1.3M |
| May 6, 2026 | Steven H Stein | Grant A | 44.1K | $0 |
| May 6, 2026 | Pablo J Cagnoni KEY | Grant A | 31.5K | $0 |
| May 4, 2026 | Suketu Upadhyay KEY | Grant A | 13.2K | $0 |
| May 4, 2026 | Suketu Upadhyay KEY | Grant A | 38.4K | $0 |
| May 4, 2026 | Suketu Upadhyay KEY | Grant A | 26.3K | $0 |
| Apr 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 12.6K | $0 |
| Apr 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 6.1K | $0 |
| Apr 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Sell S | 18.7K | $1.8M |
| Apr 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 12.6K | $905.6K |
| Apr 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 6.1K | $390.4K |
| Apr 15, 2026 | Steven H Stein | Grant A | 39.0K | $0 |
| Apr 15, 2026 | William Meury KEY | Exercise M | 125.0K | $0 |
| Apr 15, 2026 | Pablo J Cagnoni KEY | Grant A | 27.9K | $0 |
| Mar 31, 2026 | Edmund Harrigan | Grant A | 269 | $25.3K |
| Mar 31, 2026 | Paul J Clancy | Grant A | 265 | $24.9K |
| Mar 25, 2026 | Matteo Trotta | Other F | 537 | $49.5K |
| Mar 23, 2026 | Paul J Clancy | Other D | 5.4K | — |
| Mar 23, 2026 | Paul J Clancy | Other D | 20.6K | — |
| Mar 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 11.5K | $0 |
| Mar 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 7.2K | $0 |
| Mar 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Sell S | 18.7K | $1.8M |
| Mar 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 11.5K | $738.9K |
| Mar 17, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 7.2K | $438.4K |
| Feb 19, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 5.6K | $0 |
| Feb 19, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 13.1K | $0 |
| Feb 19, 2026 | Pablo J Cagnoni KEY 10b5-1 | Sell S | 18.7K | $1.9M |
| Feb 19, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 5.6K | $341.1K |
| Feb 19, 2026 | Pablo J Cagnoni KEY 10b5-1 | Exercise M | 13.1K | $808.6K |
| Feb 2, 2026 | Michael James Morrissey | Other F | 185 | $19.0K |
| Feb 2, 2026 | Lee Heeson | Other F | 111 | $11.4K |
| Jan 20, 2026 | Michael James Morrissey | Other F | 429 | $44.0K |
| Jan 16, 2026 | Patrick A Mayes | Grant A | 4.2K | $0 |
| Jan 16, 2026 | Mohamed Khairie Issa | Grant A | 14.2K | $0 |
| Jan 16, 2026 | Matteo Trotta | Grant A | 8.5K | $0 |
| Jan 16, 2026 | Thomas Tray | Grant A | 2.4K | $0 |
| Jan 16, 2026 | Michael James Morrissey | Grant A | 7.4K | $0 |
| Jan 16, 2026 | Steven H Stein | Grant A | 19.9K | $0 |
| Jan 16, 2026 | Lee Heeson | Grant A | 8.9K | $0 |
| Jan 16, 2026 | Pablo J Cagnoni KEY | Grant A | 28.5K | $0 |
| Jan 12, 2026 | Otis W Brawley | Grant A | 54.9K | $0 |
| Jan 7, 2026 | Mohamed Khairie Issa 10b5-1 | Sell S | 10.9K | $1.2M |
| Jan 6, 2026 | Mohamed Khairie Issa 10b5-1 | Other F | 8.3K | $881.4K |
| Jan 5, 2026 | Steven H Stein 10b5-1 | Sell S | 15.6K | $1.6M |
| Dec 31, 2025 | Michael James Morrissey | Other F | 254 | $25.1K |
| Dec 31, 2025 | Steven H Stein | Other F | 13.3K | $1.3M |
| Dec 31, 2025 | Edmund Harrigan | Grant A | 245 | $24.2K |
| Dec 31, 2025 | Paul J Clancy | Grant A | 241 | $23.8K |
About INCY insider trading
This page tracks insider transactions for INCYTE CORP (INCY) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.